Relative contribution of Prevotella intermedia and Pseudomonas aeruginosa to lung pathology in airways of patients with cystic fibrosis

Thorax

Volumn 65, Issue 11, 2010, Pages 978-984

  Ulrich, Martina ^a   Beer, Isabelle ^a   Braitmaier, Peter ^a   Dierkes, Michaela ^a   Kummer, Florian ^a   Krismer, Bernhard ^a   Schumacher, Ulrike ^a   Gräpler Mainka, Ute ^a   Riethmüller, Joachim ^a   Jensen, Peter Ø ^b   Bjarnsholt, Thomas ^b   Høiby, Niels ^b   Bellon, Gabriel ^c   Döring, Gerd ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b Rigshospitalet   (Denmark)

^c HOSPICES CIVILS DE LYON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL VIRULENCE; BACTERIUM CULTURE; BACTERIUM DETECTION; CLINICAL ARTICLE; COLONY FORMING UNIT; CONTROLLED STUDY; CYSTIC FIBROSIS; CYTOTOXICITY; HUMAN; INFLAMMATION; LUNG INFECTION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PREVOTELLA INTERMEDIA; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SPUTUM ANALYSIS;

EID: 78149357501     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thx.2010.137745     Document Type: Article

References (35)

1. Boucher R. New concepts of the pathogenesis of cystic fibrosis lung disease. Eur Respir J 2004;23:146-58.
2. Matsui H, Grubb BR, Tarran R, et al. Evidence for periciliary liquid layer depletion, not abnormal ion composition, in the pathogenesis of cystic fibrosis airways disease. Cell 1998;95:1005-15. (Pubitemid 29019052)
3. Döring G, Ratjen F. Immunology of cystic fibrosis. In: Hodson ME, Geddes D, Bush A, eds. Cystic fibrosis. London: Arnold Hammer, 2007:69-80.
4. Anon. Patient registry annual report. Maryland, USA: Cystic Fibrosis Foundation, 2004.
5. Cramton SE, Ulrich M, Götz F, et al. Anaerobic conditions induce expression of polysaccharide intercellular adhesin in Staphylococcus aureus and Staphylococcus epidermidis. Infect Immun 2001;69:4079-85. (Pubitemid 32493332)
6. Matsui H, Wagner VE, Hill DB, et al. A physical linkage between cystic fibrosis airway surface dehydration and Pseudomonas aeruginosa biofilms. Proc Natl Acad Sci USA 2007;103:18131-6. (Pubitemid 44871624)
7. McKenney D, Pouliot KL, Wang Y, et al. Broadly protective vaccine for Staphylococcus aureus based on an in vivo-expressed antigen. Science 1999;284:1523-7.
8. Worlitzsch D, Tarran R, Ulrich M, et al. Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. J Clin Invest 2002;109:317-25. (Pubitemid 34141805)
9. Döring G, Hoiby N; Consensus Study Group. Early intervention and prevention of lung disease in cystic fibrosis: a European consensus. J Cyst Fibros 2004;3:67-91. (Pubitemid 38987019)
10. Hill D, Rose B, Pajkos A, et al. Antibiotic susceptibilities of Pseudomonas aeruginosa isolates derived from patients with cystic fibrosis under aerobic, anaerobic, and biofilm conditions. J Clin Microbiol 2005;43:5085-90. (Pubitemid 41484009)
11. Kolpen M, Hansen CR, Bjarnsholt T, et al. The respiratory burst of polymorphonuclear leukocytes accelerates oxygen depletion in sputum from CF patients with chronic Pseudomonas aeruginosa lung infection. Thorax 2010;65:57-62.
12. Brook I, Fink R. Transtracheal aspiration in pulmonary infection in children with cystic fibrosis. Eur J Respir Dis 1983;64:51-7. (Pubitemid 13184236)
13. Jewes LA, Spencer RC. The incidence of anaerobes in the sputum of patients with cystic fibrosis. J Med Microbiol 1990;31:271-4.
14. Rogers GB, Hart CA, Mason JR, et al. Bacterial diversity in cases of lung infection in cystic fibrosis patients: 16S ribosomal DNA (rDNA) length heterogeneity PCR and 16S rDNA terminal reobligateion fragment length polymorphism profiling. J Clin Microbiol 2003;41:3548-58.
15. Rogers GB, Carroll MP, Serisier DJ, et al. Characterization of bacterial community diversity in cystic fibrosis lung infections by use of 16s ribosomal DNA terminal reobligation fragment length polymorphism profiling. J Clin Microbiol 2004;42:5176-83.
16. Rogers GB, Carroll MP, Serisier DJ, et al. Use of 16S rRNA gene profiling by terminal restriction fragment length polymorphism analysis to compare bacterial communities in sputum and mouthwash samples from patients with cystic fibrosis. J Clin Microbiol 2006;44:2601-4.
17. Tunney MM, Field TR, Moriarty TF, et al. Detection of anaerobic bacteria in high numbers in sputum from patients with cystic fibrosis. Am J Respir Crit Care Med 2008;177:995-1001.
18. Worlitzsch D, Rintelen C, Böhm K, et al. Antibiotic-resistant obligate anaerobes during exacerbations of cystic fibrosis patients. Clin Microbiol Infect 2009;15:454-60.
19. Bittar F, Riichet H, Dubus J-C, et al. Molecular detection of multiple emerging pathogens in sputa from cystic fibrosis patients. PloS One 2008;3:e2908.
20. Harris JK, De Groote MA, Sagel SD, et al. Molecular identification of bacteria in bronchoalveolar lavage fluid from children with cystic fibrosis. Proc Natl Acad Sci USA 2007;104:20529-33.
21. Gove RI, Wiggins J, Stableforth DE. A study of the use of ultrasonically nebulized lidocaine for local anaesthesia during fiberoptic bronchoscopy. Br J Dis Chest 1985;79:49-59. (Pubitemid 15162039)
22. Oliveira K, Procop GW, Wilson D, et al. Rapid identification of Staphylococcus aureus directly from blood cultures by fluorescence in situ hybridization with peptide nucleic acid probes. J Clin Microbiol 2002;40:247-51.
23. Fenselau C, Demirev PA. Characterization of intact microorganisms by MALDI mass spectrometry. Mass Spectrom Rev 2001;20:157-71. (Pubitemid 34151741)
24. Johansen HK, Nørregaard L, Gøtzsche PC, et al. Antibody response to Pseudomonas aeruginosa in cystic fibrosis patient - a marker of therapeutic success? A 30-year cohort study of survival in Danish CF patients after onset of chronic P. aeruginosa lung infection. Pediatr Pulmonol 2004;37:427-32.
25. Ulrich M, Albers C, Moller JG, et al. Moxifloxacin and azithromycin but not amoxicillin protect human respiratory epithelial cells against Streptococcus pneumoniae in vitro when administered up to 6 hours after challenge. Antimicrob Agents Chemother 2005;49:5119-22. (Pubitemid 41778929)
26. Jensen PO, Bjarnsholt T, Phipps R, et al. Rapid necrotic killing of polymorphonuclear leukocytes is caused by quorum-sensing-controlled production of rhamnolipid by Pseudomonas aeruginosa. Microbiology 2007;153:1329-38. (Pubitemid 46779989)
27. Bragonzi A, Worlitzsch D, Timpert P, et al. Non-mucoid Pseudomonas aeruginosa expresses alginate in lungs of patients with cystic fibrosis and in a murine model. J Infect Dis 2005;192:410-19. (Pubitemid 41023119)
28. Brook I. Anaerobic infections in children. Microb Infect 2002;4:1271-80.
29. Jansen HJ, Grenier D, van der Hoeven JS. Characterization of immunoglobulin G-degrading proteases of Prevotella intermedia and Prevotella nigrescens. Oral Microbiol Immunol 1995;10:138-45.
30. Döring G, Høiby N. Longitudinal study of immune response to Pseudomonas aeruginosa antigens in cystic fibrosis. Infect Immun 1983;42:197-201. (Pubitemid 13012453)
31. Ratjen F, Walter H, Haug M, et al. Diagnostic value of serum antibodies in early Pseudomonas aeruginosa infection in cystic fibrosis patients. Pediatr Pulmonol 2007;42:249-55. (Pubitemid 46417698)
32. Grenier D, Michaud J. Demonstration of human immunoglobulin G Fc-binding activity in oral bacteria. Clin Diagn Lab Immunol 1994;1:247-9. (Pubitemid 2057644)
33. Graille M, Stura EA, Corper AL, et al. Crystal structure of a Staphylococcus aureus protein A domain complexed with the Fab fragment of a human IgM antibody: structural basis for recognition of B-cell receptors and superantigen activity. Proc Natl Acad Sci USA 2000;97:5399-404. (Pubitemid 30313730)
34. Döring G, Parameswaran I, Murphy TF. Differential adaptation of microbial pathogens to airways of patients with cystic fibrosis and chronic obstructive pulmonary disease. FEMS Microbiol Rev 2010 May 28. doi:10.1111/j.1574-6976.2010.00237.
35. Smith EE, Buckley DG, Wu Z, et al. Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients. Proc Natl Acad Sci USA 2006;103:8487-92. (Pubitemid 43838482)